Bank of America’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Buy |
884,828
+355,976
| +67% | +$972K | ﹤0.01% | 3872 |
|
|
2025
Q1 | $888K | Sell |
528,852
-602,961
| -53% | -$1.01M | ﹤0.01% | 4425 |
|
|
2024
Q4 | $1.84M | Buy |
1,131,813
+115,347
| +11% | +$188K | ﹤0.01% | 3810 |
|
|
2024
Q3 | $4.23M | Buy |
1,016,466
+106,299
| +12% | +$442K | ﹤0.01% | 3318 |
|
|
2024
Q2 | $4.97M | Buy |
910,167
+362,140
| +66% | +$1.98M | ﹤0.01% | 3110 |
|
|
2024
Q1 | $5.48M | Buy |
548,027
+66,237
| +14% | +$662K | ﹤0.01% | 2990 |
|
|
2023
Q4 | $1.97M | Buy |
481,790
+79,396
| +20% | +$324K | ﹤0.01% | 3647 |
|
|
2023
Q3 | $1.56M | Buy |
402,394
+23,153
| +6% | +$89.6K | ﹤0.01% | 3734 |
|
|
2023
Q2 | $2.26M | Sell |
379,241
-303,190
| -44% | -$1.81M | ﹤0.01% | 3462 |
|
|
2023
Q1 | $2.23M | Buy |
682,431
+14,849
| +2% | +$48.6K | ﹤0.01% | 3634 |
|
|
2022
Q4 | $2.64M | Buy |
667,582
+208,968
| +46% | +$825K | ﹤0.01% | 3446 |
|
|
2022
Q3 | $2.75M | Buy |
458,614
+93,915
| +26% | +$564K | ﹤0.01% | 3394 |
|
|
2022
Q2 | $2.35M | Sell |
364,699
-14,888
| -4% | -$95.7K | ﹤0.01% | 3594 |
|
|
2022
Q1 | $3.14M | Buy |
379,587
+324,866
| +594% | +$2.68M | ﹤0.01% | 3576 |
|
|
2021
Q4 | $847K | Buy |
54,721
+43,461
| +386% | +$673K | ﹤0.01% | 4714 |
|
|
2021
Q3 | $254K | Sell |
11,260
-1,008
| -8% | -$22.7K | ﹤0.01% | 5309 |
|
|
2021
Q2 | $241K | Buy |
12,268
+3,629
| +42% | +$71.3K | ﹤0.01% | 5212 |
|
|
2021
Q1 | $289K | Buy |
+8,639
| New | +$289K | ﹤0.01% | 5136 |
|